Crombie REIT Declares September 2024 Distribution for Investors
Crombie REIT Declares September 2024 Distribution
Crombie Real Estate Investment Trust, recognized as a leader in the real estate sector, has announced an exciting development for its investors. The latest news highlights a distribution of $0.07417 per unit for the month of September 2024. This distribution reflects Crombie's ongoing commitment to delivering value to its Unitholders.
Key Details of the Distribution
The distribution period runs from the start of September until the end of September 30, 2024. Unitholders should note that this payment will be made on October 15, 2024. It’s crucial for investors to be aware that they must be listed as Unitholders by September 30, 2024, to receive this payout.
About Crombie REIT's Operations
Vision and Mission
Crombie REIT operates with a clear vision focused on community enrichment. By investing in real estate that fosters growth and sustainability, the company aims to build not just structures, but positive impacts that resonate within communities today and into the future. Their diverse portfolio includes grocery-anchored retail, retail-related industrial sites, and mixed-use residential properties.
Portfolio Overview
As of mid-2024, Crombie's impressive portfolio features 304 properties, amounting to approximately 19.3 million square feet. This robust growth is complemented by ongoing development projects, highlighting the company's strategic focus on expansion within the quality real estate sector.
Sustainable Growth and Future Development
With a significant pipeline of future projects, Crombie REIT is not just resting on its current accomplishments. The company's strategy integrates responsible development that aligns with community needs. This proactive approach strengthens Crombie's position as a significant player in the real estate market.
The Importance of Real Estate Investment
Investing in real estate has become increasingly vital in today’s economic landscape. With various sectors offering robust opportunities, real estate tends to navigate fluctuations better than many other investments. Crombie’s aggressive growth and diverse portfolio cater to a variety of market needs.
Frequently Asked Questions
What is the distribution amount announced by Crombie REIT?
Crombie REIT has announced a distribution of $0.07417 per unit for September 2024.
When will the distribution be paid out?
The distribution will be payable on October 15, 2024, to all Unitholders of record as of September 30, 2024.
What types of properties does Crombie REIT invest in?
Crombie REIT primarily invests in grocery-anchored retail, retail-related industrial properties, and mixed-use residential properties.
How extensive is Crombie REIT's property portfolio?
As of June 30, 2024, Crombie REIT's portfolio consists of 304 properties spanning approximately 19.3 million square feet.
What is Crombie REIT's overarching mission?
Crombie REIT aims to enrich communities by developing quality real estate that fosters positive impacts for the future.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Current Investigation Into Kellanova's Sale Fairness for Investors
- Grace Chapel's Transformation: Embracing the New Southall Church
- Investigation Launched into Doximity for Long-Term Shareholders
- Investigation Launched into Walgreens Boots Alliance for Investors
- Peter Thiel Predicts 2024 Election Outcome With Insight
- Orthofix Medical Inc. Faces Class Action: What Investors Should Know
- European Residential REIT Sells €748 Million Portfolio Assets
- CAPREIT Announces Significant Property Sales by ERES
- AM Best Upgrades Outlook for Taiwan’s Non-Life Insurance Sector
- Lifecore Biomedical Investors: Important September Deadline
Recent Articles
- PPG Celebrates Recognition Among World's Best Companies 2024
- Chartwell Retirement Residences Announces Distribution Update
- Survey Reveals Shift in Holiday Shopping Trends Among Consumers
- LRT Company Introduces $17 Million Senior Living Investment Deal
- Vonage Innovations: Enhancing Business Messaging with RCS
- Fengate Asset Management Launches First-Ever Sustainability Report
- Exploring AMT Title Services: A New Era in Residential Title Solutions
- Carlyle and North Bridge Forge $1 Billion Financing Partnership
- Ventas Expands Portfolio Through New Agreements With Kindred
- Roundhill Investments Achieves Significant Growth Milestone
- Moleculin Biotech Shares Insights on Glioblastoma Treatment Progress
- Forecasting Growth in the Mixed Reality Sector through 2028
- Moleculin's Strategic Update on Glioblastoma Treatment Advances
- Potential Legal Action for XPEL Investors over Fraud Allegations
- Exploring the Alarming Revelations in Edgar Mitchell's Book
- Colony Bankcorp Leaders Set for Major Financial Conference
- Investors Encouraged to Join NANO Nuclear Energy Class Action
- Norman M. Powell Takes Leadership Role in Business Law Section
- Virax Biolabs Strengthens Collaboration with Cosmos Health for Mpox Kits
- Evolectric and Geotab Forge Partnership to Drive EV Fleet Solutions
- Experience the Future of Cycling with Blix's Sol X eBike
- Kopin Unveils SXGA-R15 Microdisplay for Enhanced Inspection
- Just Salad Welcomes Fall with Seasonal Offerings and New Partners
- Investors Can Take Action in MacroGenics, Inc. Lawsuit
- Velsera's Innovative Tumor Profiling Technology Receives Approval
- Pit Crew Roofing Empowers Education Through Community Support
- Mastering Leadership: Insights from Leslie A. Rubin's Expertise
- Annex Brands Expands with New PostalAnnex Store Opening
- Exciting Spring Break Destinations for 2025 Revealed by STS Travel
- Exciting Prizes Await at Bloomsburg Fair with MDi Built
- Emotional Premiere of 'Tears' Short Film at Music Festival
- VIVA Creative Takes Center Stage at Inaugural Congressional Event
- Join Kit NA Brewing's Empowering Sober October Initiative
- Nuvalent Sees Promising Future with Analyst Upgrades and Trials
- Donegal Group Insider Transaction Signals Investor Confidence
- General Mills Outlook Brightens as Citi Boosts Price Target
- BTIG Holds Neutral Outlook on Global Net Lease Amid Asset Sales
- Stifel's New Price Target Signals Optimism for RH Growth
- Complete Solar Set to Expand through Acquisition of SunPower Assets
- Tactile Medical's Nimbl System Secures Medicare Billing Approval
- Aethlon Medical Advances Cancer Treatment With Hemopurifier
- Allarity Therapeutics Achieves Milestone in Ovarian Cancer Trial
- Mizuho Maintains Neutral Outlook on Apellis Pharmaceuticals
- Citi Shifts Strategy: Downgrades on Semiconductor Stocks Amid Risks
- Navigating Bullish and Bearish Trends in E-Mini Futures Market
- Medigene’s R&D Event on 3S TCRs: A Path to Cancer Treatment
- Biodexa Pharmaceuticals Unlocks $17 Million CPRIT Grant Funding
- Kairous Acquisition Corp. Enhances Trust Account for Business Deal
- Join Jet.AI's Upcoming Shareholder Webinar This Thursday
- Transforming Homes: Smart Automation Market Set to Surge